Published in N Engl J Med on October 25, 2001
Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion (2014) 1.43
Allogeneic versus autologous blood transfusion and survival after radical prostatectomy. Transfusion (2014) 1.00
Evaluation and management of anemia in the elderly. Am J Hematol (2014) 0.85
A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes. Am J Blood Res (2011) 0.85
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. Medicine (Baltimore) (2015) 0.81
Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia? A pilot study. World J Gastroenterol (2004) 0.75
Transfusion in elderly patients with myocardial infarction. N Engl J Med (2002) 0.75
Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med (2001) 5.43
The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion (1994) 3.03
Prudent strategies for elective red blood cell transfusion. Ann Intern Med (1992) 2.98
Aprotinin prolongs whole blood activated partial thromboplastin time but not whole blood prothrombin time in patients undergoing cardiac surgery. Anesth Analg (1995) 2.06
A new era in blood conservation. Ann Thorac Surg (1991) 2.05
Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion (1998) 1.93
Platypnea-orthodeoxia: management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv (2001) 1.88
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol (1992) 1.84
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1995) 1.80
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion (1995) 1.59
Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg (1997) 1.56
Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses. Ann Thorac Surg (1996) 1.48
Leukocyte reduction in blood component therapy. Ann Intern Med (1992) 1.44
A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41
The implications of cost-effectiveness for autologous blood procurement. Arch Pathol Lab Med (1994) 1.40
Comparison of relative coronary Doppler flow velocity reserve to stress myocardial perfusion imaging in patients with coronary artery disease. Catheter Cardiovasc Interv (2001) 1.40
Influence of adjunctive balloon angioplasty on coronary blood flow after rotational atherectomy. Cathet Cardiovasc Diagn (1995) 1.39
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients. Transfusion (1991) 1.39
Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant (2000) 1.39
A standardized method for calculating blood loss. Transfusion (1997) 1.37
The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion (1993) 1.34
Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program. Vox Sang (1999) 1.27
Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood (2001) 1.20
Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center. Int J Obstet Anesth (2009) 1.19
Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang (2009) 1.19
Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion (2001) 1.16
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer (1984) 1.12
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) (1983) 1.09
Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews. Int J Qual Health Care (1996) 1.08
The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol (1989) 1.08
Stratifying patients preoperatively for transfusion outcomes. Ann Thorac Surg (1996) 1.07
Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation and coronary artery disease. J Am Coll Cardiol (1996) 1.06
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg (1994) 1.06
Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem (1997) 1.01
Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med (1987) 1.01
Guidelines for blood utilization review. Transfusion (1994) 1.01
Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. Circulation (1996) 1.01
Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood (1991) 0.98
Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant (2001) 0.97
More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost (1996) 0.97
Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant (2004) 0.93
Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant (2000) 0.92
Role of coronary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting: a combined intravascular ultrasound Doppler flow and imaging study. J Am Coll Cardiol (1997) 0.92
Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol (1995) 0.92
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation (2000) 0.91
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion (1994) 0.90
Autologous blood donation for elective surgery. Effect on physician transfusion behavior. JAMA (1987) 0.90
Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis. Am J Med (1982) 0.90
Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. Biol Blood Marrow Transplant (2003) 0.89
Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg (1994) 0.89
Acute normovolemic hemodilution. Clin Orthop Relat Res (1998) 0.88
Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation (1994) 0.88
Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia. Arch Intern Med (1980) 0.88
Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology (1994) 0.88
Specific binding of thrombin by human peripheral blood monocytes: possible role in the clearance of activated clotting factors from the circulation. J Lab Clin Med (1982) 0.88
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial. Transfusion (1996) 0.87
Quantitative demonstration of dipyridamole-induced coronary steal and alteration by angioplasty in man: analysis by simultaneous, continuous dual Doppler spectral flow velocity. Cathet Cardiovasc Diagn (1993) 0.87
Intramyocardial muscle bridging of the coronary artery--an examination of a diastolic "spike and dome" pattern of coronary flow velocity. Cathet Cardiovasc Diagn (1994) 0.87
Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen. Biol Blood Marrow Transplant (2001) 0.87
Interventional physiology. Part XIII: Role of large pectoralis branch artery in flow through a patent left internal mammary artery conduit. Cathet Cardiovasc Diagn (1995) 0.87
Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth (2012) 0.86
Abnormal coronary flow velocity reserve after coronary artery stenting in patients: role of relative coronary reserve to assess potential mechanisms. Circulation (2000) 0.86
Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med (1981) 0.86
Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology (1995) 0.86
Identification of a 36,000-molecular weight, gag-related phosphoprotein in lymphoma cells transformed by radiation leukemia virus. J Exp Med (1984) 0.85
Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg (2000) 0.85
The rise and fall of preoperative autologous blood donation. Transfusion (2001) 0.85
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Biol Blood Marrow Transplant (2004) 0.85
Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. J Clin Oncol (1999) 0.85
Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Clin Chem (1997) 0.84
Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion (1996) 0.84
Comparison of pressure-derived fractional flow reserve with poststenotic coronary flow velocity reserve for prediction of stress myocardial perfusion imaging results. Am Heart J (1995) 0.83
Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines. Proc Natl Acad Sci U S A (1982) 0.83
Evaluation of complete blood count results from a new, on-site hemocytometer compared with a laboratory-based hemocytometer. Crit Care Med (1996) 0.82
Blood substitutes: evolution and future applications. Clin Chem (1997) 0.82
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. Am J Cardiol (1999) 0.81
Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity. Biol Blood Marrow Transplant (2002) 0.81
Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies. J Clin Oncol (1997) 0.81
Assessment of angiographically intermediate coronary artery stenosis using the Doppler flowire. Am J Cardiol (1993) 0.80
Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med (1992) 0.80
Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant (2000) 0.80
Hemodynamic rounds series II: Coronary hemodynamics for angioplasty and stenting after myocardial infarction: use of absolute, relative coronary velocity and fractional flow reserve. Cathet Cardiovasc Diagn (1998) 0.80
Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol (1993) 0.79
Compensatory eythropoiesis during routine autologous blood donation. Transfusion (1998) 0.79
Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation. Bone Marrow Transplant (2000) 0.79
Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. J Thorac Cardiovasc Surg (1997) 0.79
Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver. J Clin Invest (1983) 0.79
Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant (2001) 0.78
Percutaneous double-balloon valvuloplasty of porcine bioprosthetic valves in the tricuspid position. Cathet Cardiovasc Diagn (1990) 0.78
The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery. Transfusion (1998) 0.78
Bacterial contamination of platelets at a university hospital: increased identification due to intensified surveillance. Infect Control Hosp Epidemiol (1994) 0.78
The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion (1998) 0.78
Preleukemia in Fanconi's anemia: hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesis. J Submicrosc Cytol (1987) 0.78
Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome. Am J Med (1981) 0.78
Assessing the hemodynamic significance of coronary artery stenoses: analysis of translesional pressure-flow velocity relations in patients. J Am Coll Cardiol (1993) 0.78
Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation. Bone Marrow Transplant (2003) 0.78
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med (1996) 0.78
Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg (1999) 0.78
Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity. J Clin Invest (1984) 0.78